Gonorrhea screening: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| (22 intermediate revisions by 6 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Gonorrhea}} | |||
{{CMG}}; {{AE}} {{SaraM}} | |||
{{Gonorrhea}} | ==Overview== | ||
The U.S. Preventive Services and Task Force (USSTF) recommends screening for gonorrhea in sexually active women age 24 years and younger and in older women who are at increased risk for infection. Currently available evidence is insufficient to assess the balance of benefits and harms of screening for gonorrhea in [[heterosexual]] men. USSTF recommends at least annual screenings for gonorrhea among men who have sex with men (MSM). | |||
==Screening== | |||
The U.S. Preventive Services and Task Force (USSTF) recommends screening for gonorrhea in sexually active women age 24 years and younger and in older women who are at increased risk for infection. | |||
The table below outlines the screening recommendations for gonorrhea.<ref name="STD-guildline">{{cite web | title = 2015 Sexually Transmitted Diseases Treatment Guidelines (CDC) | url = http://www.cdc.gov/std/tg2015/screening-recommendations.htm }}</ref><ref name="Gonorrhea-recomm">Workowski KA, Bolan GA. Sexually transmitted diseases treat- ment guidelines, 2015. MMWR Recomm Rep 2015;64:60–68.</ref><ref name="USPSTF">US preventive services task forces. Gonorrhea and chlamydia screening (2014) https://www.uspreventiveservicestaskforce.org/Page/Document/ClinicalSummaryFinal/chlamydia-and-gonorrhea-screening Accessed on September 28, 2016</ref><ref name="urlGonococcal Infections Among Adolescents and Adults - STI Treatment Guidelines">{{cite web |url=https://www.cdc.gov/std/treatment-guidelines/gonorrhea-adults.htm |title=Gonococcal Infections Among Adolescents and Adults - STI Treatment Guidelines |format= |work= |accessdate=}}</ref> | |||
{| style="border: 0px; font-size: 90%; margin: 3px;" align="center" | |||
|+ | |||
! style="background: #4479BA; width: 150px;" |{{fontcolor|#FFF|Population}} | |||
! style="background: #4479BA; width: 500px;" |{{fontcolor|#FFF|Screening Recommendations}} | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC;" |'''Women''' | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
*Sexually active women under 25 years of age | |||
*Sexually active women age 25 years and older if at increased risk | |||
**Prior history of sexually transmitted infection | |||
**A new sex partner | |||
**More than one sex partner | |||
**A sex partner with concurrent partners | |||
**A sex partner who has a sexually transmitted infection | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC;" |'''Men Who have Sex With Men (MSM)''' | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
*At least annually for sexually active MSM at sites of contact (urethra, rectum, pharynx) regardless of condom use | |||
*Every 3 to 6 months if at increased risk | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC;" |'''Pregnant women''' | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
*All pregnant women under 25 years of age and older women if at increased risk | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC;" |'''HIV positive patients''' | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
*For sexually active individuals, screen at first HIV evaluation, and at least annually | |||
*More frequent screening may be indicated depending on individual risk behaviors and the local epidemiology | |||
|} | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category: | |||
{{WH}} | |||
{{WS}} | |||
[[Category:Gynecology]] | |||
[[Category:FinalQCRequired]] | |||
[[Category:Emergency mdicine]] | |||
[[Category:Disease]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Infectious disease]] | |||
[[Category:Rheumatology]] | |||
[[Category:Dermatology]] | |||
[[Category:Neurology]] | |||
[[Category:Cardiology]] | |||
[[Category:Urology]] | |||
[[Category:Gastroenterology]] | |||
Latest revision as of 19:52, 21 August 2021
|
Gonorrhea Microchapters |
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Gonorrhea screening On the Web |
|
American Roentgen Ray Society Images of Gonorrhea screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Mehrsefat, M.D. [2]
Overview
The U.S. Preventive Services and Task Force (USSTF) recommends screening for gonorrhea in sexually active women age 24 years and younger and in older women who are at increased risk for infection. Currently available evidence is insufficient to assess the balance of benefits and harms of screening for gonorrhea in heterosexual men. USSTF recommends at least annual screenings for gonorrhea among men who have sex with men (MSM).
Screening
The U.S. Preventive Services and Task Force (USSTF) recommends screening for gonorrhea in sexually active women age 24 years and younger and in older women who are at increased risk for infection. The table below outlines the screening recommendations for gonorrhea.[1][2][3][4]
| Population | Screening Recommendations |
|---|---|
| Women |
|
| Men Who have Sex With Men (MSM) |
|
| Pregnant women |
|
| HIV positive patients |
|
References
- ↑ "2015 Sexually Transmitted Diseases Treatment Guidelines (CDC)".
- ↑ Workowski KA, Bolan GA. Sexually transmitted diseases treat- ment guidelines, 2015. MMWR Recomm Rep 2015;64:60–68.
- ↑ US preventive services task forces. Gonorrhea and chlamydia screening (2014) https://www.uspreventiveservicestaskforce.org/Page/Document/ClinicalSummaryFinal/chlamydia-and-gonorrhea-screening Accessed on September 28, 2016
- ↑ "Gonococcal Infections Among Adolescents and Adults - STI Treatment Guidelines".